KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biolife Solutions (BLFS) EPS (Weighted Average and Diluted) (2017 - 2025)

Biolife Solutions (BLFS) has disclosed EPS (Weighted Average and Diluted) for 11 consecutive years, with $0.23 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) fell 55.77% to $0.23 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$0.1 through Dec 2025, up 47.37% year-over-year, with the annual reading at -$0.1 for FY2025, 47.37% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $0.23 at Biolife Solutions, up from $0.01 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $2.15 in Q4 2022, with the low at -$1.72 in Q2 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.1, with a median of -$0.22 recorded in 2024.
  • Peak annual rise in EPS (Weighted Average and Diluted) hit 637.5% in 2022, while the deepest fall reached 13253.36% in 2022.
  • Over 5 years, EPS (Weighted Average and Diluted) stood at -$0.4 in 2021, then soared by 637.5% to $2.15 in 2022, then plummeted by 115.35% to -$0.33 in 2023, then skyrocketed by 257.58% to $0.52 in 2024, then crashed by 55.77% to $0.23 in 2025.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at $0.23, $0.01, and -$0.33 for Q4 2025, Q3 2025, and Q2 2025 respectively.